Myomo Inc
AMEX:MYO
Myomo Inc
PP&E Net
Myomo Inc
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
M
|
Myomo Inc
AMEX:MYO
|
PP&E Net
$8.9m
|
CAGR 3-Years
114%
|
CAGR 5-Years
125%
|
CAGR 10-Years
N/A
|
|
![]() |
Becton Dickinson and Co
NYSE:BDX
|
PP&E Net
$6.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
![]() |
Boston Scientific Corp
NYSE:BSX
|
PP&E Net
$3.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
![]() |
Stryker Corp
NYSE:SYK
|
PP&E Net
$4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
![]() |
Abbott Laboratories
NYSE:ABT
|
PP&E Net
$10.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
PP&E Net
$4.6B
|
CAGR 3-Years
33%
|
CAGR 5-Years
28%
|
CAGR 10-Years
28%
|
Myomo Inc
Glance View
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.
See Also
What is Myomo Inc's PP&E Net?
PP&E Net
8.9m
USD
Based on the financial report for Dec 31, 2024, Myomo Inc's PP&E Net amounts to 8.9m USD.
What is Myomo Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
125%
Over the last year, the PP&E Net growth was 962%. The average annual PP&E Net growth rates for Myomo Inc have been 114% over the past three years , 125% over the past five years .